|
1
|
Piazuelo MB and Correa P: Gastric cancer:
Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Y, Lin WS, Zhu WF, Lin J, Zhou ZF,
Huang CZ, Chen G, Shi Y, Guo ZQ and Ye YB: Tumor MICA status
predicts the efficacy of immunotherapy with cytokine-induced killer
cells for patients with gastric cancer. Immunol Res. 64:251–259.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi YY, Noh SH and Cheong JH: Evolution
of gastric cancer treatment: From the golden age of surgery to an
era of precision medicine. Yonsei Med J. 56:1177–1185. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Christodoulatos GS and Dalamaga M:
Micro-RNAs as clinical biomarkers and therapeutic targets in breast
cancer: Quo vadis? World J Clin Oncol. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lauressergues D, Couzigou JM, Clemente HS,
Martinez Y, Dunand C, Bécard G and Combier JP: Primary transcripts
of microRNAs encode regulatory peptides. Nature. 520:90–93. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Voinnet O: Origin, biogenesis, and
activity of plant microRNAs. Cell. 136:669–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Di Giacomo G, Koss M, Capellini TD,
Brendolan A, Pöpperl H and Selleri L: Spatio-temporal expression of
Pbx3 during mouse organogenesis. Gene Expr Patterns. 6:747–757.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lichtenauer UD, Duchniewicz M, Kolanczyk
M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings
NR, Schulte DM, et al: Pre-B-cell transcription factor 1 and
steroidogenic factor 1 synergistically regulate adrenocortical
growth and steroidogenesis. Endocrinology. 148:693–704. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujiwara T, Katsuda T, Hagiwara K, Kosaka
N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T,
Ichikawa H, et al: Clinical relevance and therapeutic significance
of microRNA-133a expression profiles and functions in malignant
osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo J, Xia B, Meng F and Lou G: miR-133a
suppresses ovarian cancer cell proliferation by directly targeting
insulin-like growth factor 1 receptor. Tumour Biol. 35:1557–1564.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Li X, Gao S, Li C and Ma L:
MicroRNA-133a inhibits proliferation of gastric cancer cells by
downregulating ERBB2 expression. Oncol Res. 25:1169–1176. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang LK, Hsiao TH, Hong TM, Chen HY, Kao
SH, Wang WL, Yu SL, Lin CW and Yang PC: MicroRNA-133a suppresses
multiple oncogenic membrane receptors and cell invasion in
non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He B, Lin X, Tian F, Yu W and Qiao B:
MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC)
proliferation and invasion by suppressing COL1A1. J Cell Biochem.
119:338–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Chen A, Xiong L, Chen T, Tao F, Lu
Y, He Q, Zhao L, Ou R and Xu Y: miR-133a acts as a tumor suppressor
in colorectal cancer by targeting eIF4A1. Tumour Biol.
39:10104283176983892017.PubMed/NCBI
|
|
16
|
Lai C, Chen Z and Li R: MicroRNA-133a
inhibits proliferation and invasion, and induces apoptosis in
gastric carcinoma cells via targeting fascin actin-bundling protein
1. Mol Med Rep. 12:1473–1478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong Y, Ren J, Liu K and Tang LM: Tumor
suppressor role of miR-133a in gastric cancer by repressing IGF1R.
World J Gastroenterol. 21:2949–2958. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai J, Liu T, Huang P, Yan W, Guo C, Xiong
L and Liu A: USP39, a direct target of microRNA-133a, promotes
progression of pancreatic cancer via the AKT pathway. Biochem
Biophys Res Commun. 486:184–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reyes-Turcu FE, Ventii KH and Wilkinson
KD: Regulation and cellular roles of ubiquitin-specific
deubiquitinating enzymes. Annu Rev Biochem. 78:363–397. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lygerou Z, Christophides G and Séraphin B:
A novel genetic screen for snRNP assembly factors in yeast
identifies a conserved protein, Sad1p, also required for pre-mRNA
splicing. Mol Cell Biol. 19:2008–2020. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clague MJ, Barsukov I, Coulson JM, Liu H,
Rigden DJ and Urbé S: Deubiquitylases from genes to organism.
Physiol Rev. 93:1289–1315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Leuken RJ, Luna-Vargas MP, Sixma TK,
Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle
checkpoint integrity and controls mRNA-levels of aurora B. Cell
Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan X, Sun X, Shi X, Wang H, Wu G, Jiang
C, Yu D, Zhang W, Xue B and Ding Y: USP39 promotes colorectal
cancer growth and metastasis through the Wnt/β-catenin pathway.
Oncol Rep. 37:2398–2404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin Z, Xiong L and Lin Q:
Ubiquitin-specific protease 39 is overexpressed in human lung
cancer and promotes tumor cell proliferation in vitro. Mol Cell
Biochem. 422:97–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y,
Yang S and Zhang X: Knockdown of USP39 induces cell cycle arrest
and apoptosis in melanoma. Tumour Biol. 37:13167–13176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gan Z, Han K, Lin S, Hu H, Shen Z and Min
D: Knockdown of ubiquitin-specific peptidase 39 inhibited the
growth of osteosarcoma cells and induced apoptosis in vitro. Biol
Res. 50:152017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li W, Chen A, Xiong L, Chen T, Tao F, Lu
Y, He Q, Zhao L, Ou R and Xu Y: miR-133a acts as a tumor suppressor
in colorectal cancer by targeting eIF4A1. Tumour Biol.
39:10104283176983892017.PubMed/NCBI
|
|
28
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Yu Q, Huang L and Yu P:
Lentivirus-mediated inhibition of USP39 suppresses the growth of
gastric cancer cells via PARP activation. Mol Med Rep. 14:301–306.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H,
Wang W, Wang T, Song L, Ma C, et al: Important role of SUMOylation
of Spliceosome factors in prostate cancer cells. J Proteome Res.
13:3571–3582. 2014. View Article : Google Scholar : PubMed/NCBI
|
